Pesticides and their binary combinations as P-glycoprotein inhibitors in NIH 3T3/MDR1 cells

Environmental Toxicology and Pharmacology

Volumn 22, Issue 3, 2006, Pages 268-276

  Pivčević, Branka ^a   Žaja, Roko ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Binary combinations; Calcein acetoxymethyl ester; MDR; NIH 3T3 MDR1; P glycoprotein; Pesticides

Indexed keywords

DIMPYLATE; ENDOSULFAN; GLYCOPROTEIN P INHIBITOR; MULTIDRUG RESISTANCE PROTEIN 1; PESTICIDE; PHOSALONE; PROPICONAZOLE; VERAPAMIL;

ANIMAL CELL; ARTICLE; CALCULATION; CONTROLLED STUDY; DRUG POTENCY; FIBROBLAST CULTURE; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 33748958170     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2006.04.002     Document Type: Article

References (47)

1. Albertus J.A., and Laine R.O. Enhanced xenobiotic transporter expression in normal teleost hepatocytes: response to environmental and chemotherapeutic toxins. J. Exp. Biol. 204 (2001) 217-227
2. Bain L.J., and LeBlanc G.A. Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein. Toxicol. Appl. Pharmacol. 141 (1996) 288-298
3. Bain L.J., McLachlan J.B., and LeBlanc G.A. Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein. Environ. Health Perspect. 105 (1997) 812-818
4. Balayssac D., Authier N., Cayre A., and Coudore F. Does inhibition of P-glycoprotein lead to drug-drug interactions?. Toxicol. Lett. 156 (2005) 319-329
5. Bard S.M. Multixenobiotic resistance as a cellular defense mechanism in aquatic organisms. Aquat. Toxicol. 48 (2000) 357-389
6. Bodo A., Bakos E., Szeri F., Varadi A., and Sarkadi B. The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol. Lett. 140/141 (2003) 133-143
7. Bruggermann E.P., Currier S.J., Gottesman M.M., and Pastan I. Characterization of the azidopine and vinblastine binding site of P-glycoprotein. J. Biol. Chem. 267 (1992) 21020-21026
8. Buss D.S., McCaffery A.R., and Callaghan A. Evidence for p-glycoprotein modification of insecticide toxicity in mosquitoes of the Culex pipiens complex. Med. Vet. Entomol. 16 (2002) 218-222
9. Cavret S., Videmann B., Mazallon M., and Lecoeur S. Diazinon cytotoxicity and transfer in Caco-2 cells: Effect of long-term exposure to the pesticide. Environ. Toxicol. Pharmacol. 20 (2005) 375-380
10. Choi K., Frommel T.O., Stern R.K., Perez C.F., Kriegler M., Tsuruo T., and Roninson I.B. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7386-7390
11. Cornwall R., Hooland Toomey B., Bard S., Bacon C., Jarman W.M., and Epel D.D. Characterization of multixenobiotic multidrug transport in the gills of the mussel Mytilus californianus and identification of environmental substrates. Aquat. Toxicol. 31 (1995) 277-296
12. De Lorenzo M.E., Scott G.I., and Ross P.E. Toxicity of pesticides to aquatic microorganisms: a review. Environ. Toxicol. Chem. 20 (2001) 84-98
13. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Meth. 89 (1986) 271-277
14. Galgani F., Cornwall R., Hooland Toomey B., and Epel D.D. Interaction of environmental xenobiotics with a multixenobiotic defence mechanism in the bay mussel Mytilus galloprovincialis from the coast of California. Environ. Toxicol. Chem. 15 (1996) 325-331
15. Gottesman M.M., and Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62 (1993) 385-427
16. Gülden M., Mürchel S., Tahan S., and Seibert H. Impact of protein binding on the availability and cytotoxic potency of organochlorine pesticides and chlorophenols in vitro. Toxicology 175 (2002) 201-213
17. Homolya L., Hollo Z., Germann U.A., Pastan I., Gottesman M.M., and Sarkadi B. Fluorescent cellular indicators are extruded by the multidrug resistance protein. J. Biol. Chem. 268 (1993) 21493-21499
18. Hollo Z., Homolya L., Davis C.W., and Sarkadi B. Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim. Biophys. Acta Biomembr. 1191 (1994) 384-388
19. Juliano R.L., and Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455 (1976) 152-162
20. Kartner N., Riordan J.R., and Ling V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221 (1983) 1285-1288
21. Lanning C.L., Fine R.L., Sachs C.W., Rao U.S., Corcoran J.J., and Abou-Donia M.B. Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein P-glycoprotein. J. Toxicol. Environ. Health 47 (1996) 395-407
22. Lanning C.L., Ayad H.M., and Abou-Donia M.B. P-glycoprotein involvement in cuticular penetration of [C-14]thiodicarb in resistant tobacco budworms. Toxicol. Lett. 85 (1997) 127-133
23. Lehnert M., de Giuli R., Kunke K., Emerson S., Dalton W.S., and Salmon S.E. Serum can inhibit reversal of multidrug resistance by chemosensitisers. Eur. J. Cancer 32A (1996) 862-867
24. Leslie E.M., Deeley R.G., and Cole S.P.C. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 204 (2005) 216-237
25. Litman T., Zeuthen T., Skovskgaard T., and Stein W.D. Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity. Biochim. Biophys. Acta 1361 (1997) 159-168
26. Litman T., Druley T.E., Stein W.D., and Bates S.E. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. 58 (2001) 931-959
27. Luckenbach T., and Epel D. Nitromusk and polycyclic musk compounds as long-term inhibitors of cellular xenobiotic defense systems mediated by multidrug transporters. Environ. Health Perspect. 113 (2005) 17-24
28. Mayer U., Wagenaar E., Dorobek B., Beijnen J.H., Borst P., and Schinkel A.H. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J. Clin. Invest. 100 (1997) 2430-2436
29. Pohl A., Devaux P.F., and Herrmann A. Function of procaryotic and eukaryotic ABC proteins in lipid transport. Biochim. Biophys. Acta (1733) 29-52
30. Schantz S.L., and Widholm J.J. Cognitive effects of endocrine-disrupting chemicals in animals. Environ. Health Perspect. 109 (2001)
31. Schinkel A.H., Smit J.J.M., Van Tellingen O., Beijnen J.H., Wagenaar E., Van Deemter L., Mol C.A.A.M., Van Der Valk M.A., Robanus-Maandag E.C., Te Riele H.P.J., Berns A.J.M., and Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to the increased sensitivity to drugs. Cell 77 (1994) 491-502
32. Schinkel A.H., Mayer U., Wagenaar E., Mol C.A.A.M., Vandeemeter L., Smit J.J.M., Vandervalk M.A., Voordouw A.C., Spits H., Vantellingen O., Zijlmans J.M.J.M., Fibbe W.E., and Borst P. Normal viability and altered pharmacokinetics in mice lacking MDR1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4028-4033
33. Schwab D., Fischer H., Tabatabaei A., Poli S., and Huwyler J. Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery. J. Med. Chem. 46 (2003) 1725
34. Shabbir A., DiStasio S., Zhao J., Cardozo C.P., Wolff M.S., and Caplan A.J. Differential effects of the organochlorine pesticide DDT and its metabolite p,p′-DDE on P-glycoprotein activity and expression. Toxicol. Appl. Pharmacol. 203 (2005) 91-98
35. Shao Y., Ayesh S., and Stein W.D. Mutually co-operative interactions between modulators of P-glycoprotein. Biochim. Biophys. Acta 1360 (1997) 30-38
36. Smital T., Luckenbach T., Sauerborn R., Hamdoun A., Vega R.L., and Epel D. Emerging contaminants-pesticides, PPCPs, microbial degradation products and natural substances as inhibitors of multixenobiotic defense in aquatic organisms. Mutat. Res. 552 (2004) 101-117
37. Smith B.J., Doran A.C., McLean S., Tingly F.D., O'Neill B.T., and Kajiji S.M. P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonist. J. Pharmacol. Exp. Ther. 298 (2001) 1252-1259
38. Srinivas R., Udikeri S.S., Jayalakshmi S.K., and Sreeramulu K. Identification of factors responsible for insecticide resistance in Helicoverpa armigera. Comp. Biochem. Physiol., Part C 137 (2004) 261-269
39. Tallarida R.J., Stone D.J., and Raffa R.B. Efficient designs for studying synergistic drug combinations. Life Sci. 61 (1997) PL417-PL425
40. Tallarida R.J. The interaction index: a measure of drug synergism. Pain 98 (2002) 163-168
41. Tang-Wai D.F., Kajiji S., DiCapua F., de Graaf D., Roninson I.B., and Gros P. Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochemistry 34 (1995) 32-39
42. Thiebaut F., Tsuro T., Hamada H., Gottesman M.M., Pastan I., and Willingham M.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 7735-7738
43. Tiberghien F., and Loor F. Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay. Anti-Cancer Drugs 7 (1996) 568-578
44. Toomey B.H., and Epel D. A multixenobiotic transporter in Urehis caupo embryos: protection from pesticides?. Mar. Environ. Res. 39 (1995) 299-302
45. Varma M.V.S., Ashokray Y., Dey C.S., and Panchagnula R. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol. Res. 48 (2003) 347-359
46. Waldman P., Pivčević B., Müller W.E.G., Zahn R.K., and Kurelec B. The ecotoxicological relevance of multixenobiotic mechanism in aquatic organisms: example, the fresh water mussel Corbicula fluminea. Mutat. Res. 342 (1995) 113-123
47. Wang R.B., Kuo C.L., Lien L.L., and Lien E.J. Structure-activity relationship: analyses of P-glycoprotein substrates and inhibitors. J. Clin. Pharmacol. Therap. 28 (2003) 203-228